Biosimilars Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1290 | Report Format : | Status : Upcoming |

Abstract

Global Biosimilars Market: Overview

Biosimilar is a biopharmaceutical product which is similar to the previous or the original existing product that is manufactured by a company. The biosimilar also has alternative names such as subsequent entry biologic or follow-on biologic. When the patent of the original product expires biosimilars can be manufactured which are approved officially. When the patent expires of an approved recombinant drug any other biotech company can generate and market these biologics, thus the name biosimilars.

Global Biosimilars Market: Segmentation

The global biosimilars market is segmented into its product, manufacturing type and application. Based on the product, the market is segregated into recombinant non-glycosylated proteins, recombinant peptides, and recombinant glycosylated proteins. Further, the recombinant non-glycosylated proteins are sub-segmented into granulocyte colony-stimulating factor, interferons, insulin, and recombinant human growth hormones. The recombinant glycosylated proteins segment is sub-segmented into urofollitropin, erythropoietin, and monoclonal antibodies. the insulin and granulocyte colony-stimulating factor segment is sub-segmented into calcitonin and glucagon. On the basis of the manufacturing type, the market is categorized into contract manufacturing organizations and in-house manufacturing. On the basis of application, the market is divided into blood disorders, growth hormone deficiency, oncology, chronic & autoimmune diseases, infectious diseases, and others.

Global Biosimilars Market: Growth Factors

The major factor that contributed to the biosimilars market growth is the emergence of the biologic products that are off-patent. These drugs are very cost-effective thus making its demand to increase substantially. In the coming years, this demand for the biosimilars is going to increase. The increasing rate of the diseases across the globe has also helped in contributing towards the market growth. The manufacturers of the biologic drug have started to take initiatives in making innovative strategies in order to develop the biosimilars market. Even though the market is in a phase where it is flourishing there are some restraining factors that are affecting the market growth. The factors such as lengthy clinical trials which are required from the regulatory bodies for approval and the production of biosimilars require complex infrastructure are affecting the market growth.

Global Biosimilars Market: Regional Analysis

The biosimilars market is geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World. The region that is leading the biosimilars market is Europe and it accounts for the largest share in the global market. The factors that have attributed to this growth are Omni trope, bino crits, and lenograstim. Additionally, the strict regulatory framework and the increasing pipeline products estimate to contribute towards the growth of the European biosimilars market. There are opportunities increasing in the regions such as Asia Pacific region. As per the study, the Asia-Pacific region will have a progressive growth rate in the coming years. The stringent protocols in the US are hampering the biosimilars market in the North American region.

Global Biosimilars Market: Competitive Players

The key market players in the biosimilars market include Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Biocon Ltd., F. Hoffmann-La Roche Ltd., Samsung Bioepis, Sandoz International GmbH, Amgen Inc., Dr. Reddy’s Laboratories Ltd. and Celltrion, Inc.

Global Biosimilars Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Immuno-oncology Therapy Market by Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines) and by Therapeutic Areas, for Hospitals, Clinics, ASC’s and Cancer Research Institutes: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Jan-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2534 | Report Format:

The report covers forecast and analysis for the immuno-oncology therapy market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the immuno-oncology therapy mar...Read More

Compounding Pharmacies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2525 | Report Format:

Global Compounding Pharmacies Market: Overview Compounding is the knowledge of preparing and combining tailored medicines for users. These medicines are made on the basis of the prescription from the practitioner wherein, the separate ingredients are blended together according to the recommended...Read More

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Choose License Type:
Latest Published Reports

View All Published Reports